3-Bromo-5,6,7,8-tetrahydroquinoline, 95.0%, 250mg

L-tert-Leucine>98.0%(T)25g

(3-Methyl-4-propan-2-yloxyphenyl)methanol, 95%, 5g

N-((4aR,6S,7R,8R,8aS)-6-(Benzyloxy)-8-hydroxy-2-phenylhexahydropyrano[3,2-d][1,3]dioxin-7-yl)acetamide, 95.0%, 1g

3,5-Dibromo-2-chloro-pyridine, 95.0%, 25g

2-Chloro-6-fluoro-3-(methoxymethoxy)benzoic acid, 98%, 1g

GC capillary column ROTI®Cap-5 MS, 30 m, 0.32 mm, 0.25 µm, 1 Piece(s)

Analytical and precision scale Pioneer® series Models with internal adjustment, not certified, 0.00001 / 0.0001 g, 52/120 g, PX125D (W)

Dibenzo[b,d]furan-2-ylboronic acid, 95.0%, 5g

4-Methyl-2-pentanone Oxime>98.0%(GC)25mL

2-Fluoro-4-(trifluoromethyl)phenylacetic acid, 98.0%, 10g

1-(3-(Difluoromethyl)-1-methyl-1H-pyrazol-4-yl)ethan-1-one, 97%, 250mg

4-Chloro-1,3-dimethyl-1H-pyrazole-5-carboxylic acid, 95.0%, 10g